TMJD Trial Now Recruiting in Maryland

The University of Maryland Dental School is recruiting patients for a clinical trial to see if the drug duloxetine (Cymbalta) relieves pain of temporomandibular joint dysfunction. Duloxetine is an antidepressant also approved by the United States Food and Drug Administration (FDA) for the treatment of chronic pain of diabetic nerves and fibromyalgia. If duloxetine has a therapeutic effect, it could be the basis for use in patients with painful temporomandibular joint and muscle disorders. Dr. Sharon Gordon, the principal investigator of the study, is available to answer any questions you may have and provide further information on the study. Contact her at 410-706-6345 or painfree@umaryland.edu.

Links to a patient information flyer, the clinical study consent form and Dr. Gordon's biographical information are provided. If you have any questions or concerns that we may address, contact us at 262-432-0350 or info@tmj.org.